In drug-resistant ovarian cancer cell lines, high expression of BCRP and multidrug resistance protein 1 (MDR1) was accompanied by ALDH1A1 overexpression, and the inhibition of ALDH activity reduced drug efflux transporter expression, leading to sensitization to chemotherapy21. Here, ABCG2 is linked to ovarian carcinoma.